Which hedge funds own PCRX? PACIRA BIOSCIENCES INC, Q2 2026 13F holders
28 tracked hedge funds disclosed a position in PCRX (PACIRA BIOSCIENCES INC) in their Q2 2026 13F filings, worth $231.3m in total. The largest holder by portfolio weight is Doma Perpetual Capital Management LLC at 16.4% of its book. 8 opened a new position this quarter: Campbell & CO Investment Adviser LLC, Quantbot Technologies LP, ExodusPoint Capital Management, LP, Voleon Capital Management LP. 4 exited: EntryPoint Capital, LLC, Balyasny Asset Management L.P., Voloridge Investment Management, LLC.
- 28
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 8
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 4
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $6.4m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $4.2m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $231m
- Combined value Sum of the holders' reported positions in the security.
- 2.3%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| EntryPoint Capital, LLC | 0.1% | $481k |
| Balyasny Asset Management L.P. | 0.0% | $2.4m |
| Voloridge Investment Management, LLC | 0.0% | $447k |
| Arrowstreet Capital, Limited Partnership | 0.0% | $835k |
Ownership over time
Who discovered PCRX first? Beta
| Deerfield Management Company, L.P. | Q1 2020 | +2.0 pts |
| PFM Health Sciences, LP | Q1 2017 | +1.3 pts |
| Avoro Capital Advisors LLC | Q1 2017 | +0.4 pts |
| Stonepine Capital Management, LLC high conviction | Q3 2017 | 0.0 pts |
| Matrix Capital Management Company, LP | Q4 2014 | −0.5 pts |
| Armistice Capital, LLC | Q3 2016 | −0.7 pts |
| Standard Investments LLC high conviction | Q4 2015 | −0.9 pts |
| Sarissa Capital Management LP high conviction | Q4 2015 | −1.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.